Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study

Published:2011-07-28 Issue:8 Volume:11 Page:1665-1675
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Lebranchu Y.,Thierry A.,Thervet E.,Büchler M.,Etienne I.,Westeel P. F.,de Ligny B. Hurault,Moulin B.,Rérolle J. P.,Frouget T.,Girardot-Seguin S.,Toupance O.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2011.03637.x/fullpdf

Reference45 articles.

1. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transplant,2004

2. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology;Nankivell;Transplantation,2004

3. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients;Kreis;Transplantation,2000

4. Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine;Groth;Sirolimus European Renal Transplant Study Group. Transplantation,1999

5. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years;Flechner;Am J Transplant,2004

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Glomerulus: Mechanisms and Patterns of Injury;Reference Module in Biomedical Sciences;2024

2. Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation;Transplantation Proceedings;2023-05

3. Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis;Journal of Clinical Medicine;2022-07-20

4. Early conversion to a CNI-free immunosuppression with SRL after renal transplantation—Long-term follow-up of a multicenter trial;PLOS ONE;2020-08-05

5. Renal disease in the allograft recipient;Best Practice & Research Clinical Gastroenterology;2020-06